#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mantle cell lymphoma refractory Vascular malformation Partial lipodystrophy Cutaneous T-cell lymphoma Hepatocellular carcinoma Metastases to peritoneum Behcet's syndrome Arginase deficiency Gastrointestinal neuroendocrine tumour Necrotising myositis Chronic lymphocytic leukaemia recurrent Immune-mediated renal disorder Sjogren's syndrome Macular telangiectasia Cardiac sarcoidosis More trials…

    Learn about Rare Diseases

    Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Primary biliary cholangitis Rhabdomyosarcoma Hepatic angiosarcoma Prader-Willi syndrome – Basic Information Wiskott-Aldrich syndrome – Trials in Disease Waldenstrom’s macroglobulinaemia refractory – Life with Disease Glycogen storage disease type II – Trials in Disease Haemophilia Aicardi-Goutieres syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Fluoride (18F) Ubiquinol Doxazosin Mesilate ALXN2420 Pc14586 Aluminium Vatiquinone Ovolecithin Immunoglobulin G Arginine Hydrochloride 12 Grass Pollen Mixture AZD0516 Ambrisentan Aripiprazole Gns561 Dexamethasone Acetate Enzalutamide Mva-209-Fsp-B2 Elebsiran Febuxostat More therapies…

    Learn about Your Condition

    Incontinence Vitiligo Hairy cell leukaemia recurrent Alopecia areata Polymyalgia rheumatica Infective uveitis Constipation Carotid artery occlusion Demyelination Laryngeal cancer stage I HER2 positive gastric cancer Pneumonia Metabolic disorder Radius fracture Adenomatous polyposis coli More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Hydroxychloroquine for Women with Recurrent Pregnancy Loss

    Recruiting

    2 1 1
    Investigated Diseases:
    • Habitual abortion
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    Denmark

  • Study on the Safety and Effectiveness of Venetoclax with Fludarabine, Amsacrine, and Cytarabine for Patients with MDS, CMML, or Secondary AML Undergoing Stem Cell Transplantation

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Leukaemia
    Investigated Drugs:
    • Amsacrine
    • Febuxostat Hemihydrate
    • Rasburicase
    Germany

  • Study on Nifedipine for Managing Preterm Premature Rupture of Membranes (PPROM) in Pregnant Women Before 34 Weeks

    Recruiting

    3 1 1
    Investigated Diseases:
    • Premature rupture of membranes
    Investigated Drugs:
    • Nifedipine
    France

  • Long-Term Safety Study of Gene Therapy with Etuvetidigene Autotemcel for Patients with Wiskott-Aldrich Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    • Wiskott-Aldrich syndrome
    Investigated Drugs:
    • Etuvetidigene Autotemcel
    France

  • Study on the Effectiveness and Safety of Sublingual MM09 for Patients Aged 12-65 with Allergies to House Dust Mites and Rhinitis/Rhinoconjunctivitis with or without Asthma

    Recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Mite allergy
    • Rhinitis allergic
    Investigated Drugs:
    • Dermatophagoides Farinae Extract
    • Dermatophagoides Pteronyssinus Extract
    Portugal Spain

  • Study of Efgartigimod PH20 SC for Children Aged 2 to 17 with Generalized Myasthenia Gravis

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Efgartigimod Alfa
    Belgium Czechia France Germany Italy The Netherlands +2
Previous Page
1 … 322 323 324 325 326 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!